Abbvie's piece of the pie will be nothing at the price of over $83,000. Why would any doctor or provider prescribe multiple pills (Abbvie) a day over the one pill a day, and more effective Harvoni? Especially when eight weeks of Harvoni is just over $63,000 for the treatment naive.
Gilead takes the entire market once again. Not a smart decision on behalf of Abbvie IMO. Very disappointing there still isn't any competition for Gilead.
-Rob
lilbit said
Dec 20, 2014
Matt didn't I read they were going to use Riba with Harvoni for certain people? Not everyone gets Riba with Abbvies either. I have a friend on it without and she is having no side effects.
Cinnamon Girl said
Dec 20, 2014
Thanks for posting this, Malcolm, we were expecting Abbvie to get FDA approval for this combo any time now.
It will be very interesting to see how many doctors prescribe it over Harvoni, especially at that price. The success rates are impressive with minimal side effects but as Matt said, the need to take Ribavirin doesn`t go in its favour.
Another option for Genotype 1`s though and good luck to Abbvie, at least Gilead has some competition.
Beacon said
Dec 20, 2014
Dec 19 (Reuters) - U.S. health regulators on Friday approved AbbVie's all-oral treatment for hepatitis C, and the company said the drug would cost $83,319 for a typical 12-week plan.
Matt Chris said
Dec 19, 2014
Hey Lilbit
I agree, we all thought that Abbvie would price a little less than Gileads Harvoni. I did the Abbvie meds for 12 weeks and now started the Gilead's and can say that they are not that much different but the pill burden and the Ribavirin will make the choice for most Doctors IMO for Harvoni. Let the battle begin, I'm sure they have other behind the wall deals with some big pharmacy and insurance concerns. For right now IMO Sofosbuvir does not have an equal and that will sway many patients
matt
lilbit said
Dec 19, 2014
From what Beacon posted it isn't going to be that much less expensive which disappoints me. I just finished this regiem as a trial and am super happy it has been approved. But my husband still needs treatment and hopefully the insurance will cover it. So far it has worked well for me. On the 29th I go in for EOT + 4 week labs. Hopefully I will still be undetected.
Rubye said
Dec 19, 2014
I hope so much that their price is seriously lower than Harvoni so more Medicaid people can gain treatment. Here in Oregon the doctors keep telling people to wait for Abbvie because it will be less expensive. We shall see.
mallani said
Dec 19, 2014
Hi all,
As expected, the AbbVie combo obtained FDA approval. The price has not been announced as yet. Good luck to them-they'll need it to get a slice of the HCV treatment pie. Cheers.
Abbvie's piece of the pie will be nothing at the price of over $83,000. Why would any doctor or provider prescribe multiple pills (Abbvie) a day over the one pill a day, and more effective Harvoni? Especially when eight weeks of Harvoni is just over $63,000 for the treatment naive.
Gilead takes the entire market once again. Not a smart decision on behalf of Abbvie IMO. Very disappointing there still isn't any competition for Gilead.
-Rob
Thanks for posting this, Malcolm, we were expecting Abbvie to get FDA approval for this combo any time now.
It will be very interesting to see how many doctors prescribe it over Harvoni, especially at that price. The success rates are impressive with minimal side effects but as Matt said, the need to take Ribavirin doesn`t go in its favour.
Another option for Genotype 1`s though and good luck to Abbvie, at least Gilead has some competition.
Hey Lilbit
I agree, we all thought that Abbvie would price a little less than Gileads Harvoni. I did the Abbvie meds for 12 weeks and now started the Gilead's and can say that they are not that much different but the pill burden and the Ribavirin will make the choice for most Doctors IMO for Harvoni. Let the battle begin, I'm sure they have other behind the wall deals with some big pharmacy and insurance concerns. For right now IMO Sofosbuvir does not have an equal and that will sway many patients
matt
Hi all,
As expected, the AbbVie combo obtained FDA approval. The price has not been announced as yet. Good luck to them-they'll need it to get a slice of the HCV treatment pie. Cheers.
http://www.nytimes.com/2014/12/20/business/abbvie-wins-approval-of-hepatitis-c-treatment.html?_r=0